DEA reach goes global, beyond drugs: report

CHICAGO — Eight former U.S. drug chiefs warned the federal government Tuesday that time is running out to nullify Colorado and Washington’s new laws legalizing recreational marijuana use, and a United Nations agency also urged challenges to the measures it says violate international treaties. The former Drug Enforcement Administration chiefs criticized Barack Obama’s administration for moving too slowly to file a lawsuit that would force the states to rescind the legislation. Marijuana is illegal under federal law.

DEA official can't answer the questions: Are crack cocaine, heroin, and meth worse than marijuana?  

A North Korean embassy in Eastern Europe received a large batch of illegal drugs from the North Korean government last year, according to reports in South Korean press.

ByJoseph Dedvukaj:Retail investors were right and Wall Street was wrong about the approval of Arena Pharmaceuticals' (ARNA) lead drug candidate Belviq (Lorcaserin).

US authorities have obtained a secret court order to force search giant Google and a small Internet provider to hand over information from email accounts of a volunteer for whistleblower website WikiLeaks, a report said.The Wall Street Journal, citing documents it had reviewed, said the Internet service provider Sonic had been forced to turn over the data from the email of Wikileaks volunteer Jacob Appelbaum.

CHICAGO (AP) — Eight former Drug Enforcement Administration chiefs say the federal government needs to act now or it might lose the chance to nullify Colorado and Washington's laws legalizing recreational marijuana use. The onetime DEA heads plan to issue joint statements Tuesday saying the Obama administration has reacted too slowly and should immediately sue to force the states to rescind the legislation.

The Burrill Report submits: Novartis (NVS) says its late-stage multiple sclerosis drug, Gilenia, slows the disability's progression and reduces annual relapse rates, bolstering its lead in the race to be first to reach the $8.6 billion MS treatment market with an oral MS treatment.